Antiviral Chemistry and Chemotherapy Impact Factor in Chemistry Journals

Antiviral Chemistry and Chemotherapy in Chemistry Journals

Journal Country: United Kingdom
Journal Q tier: Q2
Publishing Firm: SAGE Publications Inc.
History: 1991-2015, 2017-2022
Journal Homepage: Not Available
Journal ISSN: 20402066, 09563202

Research Categories

Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Virology (Q3)

Impact Score: 2.39
h-Index: 57
SJR: 0.518
Ranking: 10009

About Antiviral Chemistry and Chemotherapy

Antiviral Chemistry and Chemotherapy is a journal covering the technologies/fields/categories related to Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Virology (Q3). It is published by SAGE Publications Inc.. The overall rank of Antiviral Chemistry and Chemotherapy is 10009.According to SCImago Journal Rank (SJR), this journal is ranked 0.518. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 57. The best quartile for this journal is Q2.The ISSN of Antiviral Chemistry and Chemotherapy journal is 20402066, 09563202.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Antiviral Chemistry and Chemotherapy is cited by a total of 80 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.